Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 29, 2026 08:00 ET | Source: Medidata Solutions, Inc.

Medidata Champions Collaborative Scientific Advancement at ASCO with New Research on Oncology Protocol Optimization and CAR T Efficacy

NEW YORK, May 29, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, will present two poster presentations...
May 28, 2026 08:00 ET | Source: Actinogen Medical

Actinogen receives positive EMA scientific advice aligned with prior FDA guidance for its Alzheimer’s disease program

SYDNEY, May 28, 2026 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) today announces the successful outcome of its scheduled scientific advice meeting (written response) on Alzheimer’s...
May 28, 2026 08:00 ET | Source: Medidata Solutions, Inc.

Medidata’s Next-Gen AI Imaging Solution Delivers Unprecedented Speed and Precision for Clinical Trials

NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, today unveiled its enhanced, AI-powered imaging solution, within the...
May 27, 2026 02:00 ET | Source: Predictive Health Intelligence

New study reveals promising new way to find serious liver disease earlier

Liver disease is often found late because people have no symptoms. This research shows how using existing NHS blood test data could help change that.
May 26, 2026 02:00 ET | Source: Tilray Brands, Inc.

Tilray Medical Brings Global Medical Cannabis Expertise to Cannabis Europa London 2026

LONDON, May 26, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc....
May 26, 2026 01:15 ET | Source: Novartis Pharma AG

New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength

Late-breaking Phase III IgAN data for Vanrafia ALIGN and Fabhalta APPLAUSE-IgAN studies to be presented124-week Phase I/II zigakibart data evaluating treatment efficacy and safety in IgAN will be...
May 20, 2026 09:36 ET | Source: Research and Markets

In Silico Clinical Trials Strategic Business Research Report 2026-2032: Use in Rare Disease and Orphan Drug Development Expands Application Scope, Rising R&D Costs in Drug Development Spur Demand

Dublin, May 20, 2026 (GLOBE NEWSWIRE) -- The "In Silico Clinical Trials - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for In Silico...
May 19, 2026 08:00 ET | Source: Science 37, Inc.

Science 37 and Tufts CSDD Publish Landmark Study on Direct-to-Patient Clinical Trial Site Performance, Outperforming Industry Benchmarks

Tufts CSDD completes peer-reviewed analysis of Science 37’s Direct-to-Patient Clinical Trial Site, comparing performance to industry benchmarks.
May 19, 2026 07:30 ET | Source: Vertero Therapeutics, Inc.

Vertero Advances into Phase 1b Study with VT-5006 for the Treatment of Parkinson’s Disease

Vertero doses first Parkinson’s patient in Phase 1b study of VT-5006, a gut-selective therapy targeting disease progression.
May 19, 2026 06:30 ET | Source: Avance Clinical

Avance Clinical to Showcase Oncology Leadership at ASCO Annual Meeting 2026

Meet Avance Clinical's Oncology Center of Excellence expert team at ASCO Annual Meeting in Chicago, held 29 May – 2 June 2026.